In the context of CF, where chronic infection and sustained inflammatory activation drive progressive airway damage, a reduction in ADAM33-mediated remodeling could contribute to attenuated disease severity, aligning with the protective directionality identified in the present analysis. This evidence concerns the gene ADAM33 and cystic fibrosis.